Approval · Notice of Compliance 1745 · 1999
COSOPT: Notice of Compliance 1745
Issued May 10, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1745
- Date
- May 10, 1999
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COSOPT | 02240113 | Marketed |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML